大塚ホールディングスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/06/15 | 4,394 | 4,395 | 4,306 | 4,311 | -72 | -1.6% | 764,400 |
| 2022/06/14 | 4,406 | 4,426 | 4,366 | 4,383 | -74 | -1.7% | 862,500 |
| 2022/06/13 | 4,381 | 4,464 | 4,381 | 4,457 | +21 | +0.5% | 835,800 |
| 2022/06/10 | 4,474 | 4,474 | 4,424 | 4,436 | -29 | -0.6% | 1,085,100 |
| 2022/06/09 | 4,450 | 4,492 | 4,431 | 4,465 | +36 | +0.8% | 865,800 |
| 2022/06/08 | 4,396 | 4,433 | 4,365 | 4,429 | +75 | +1.7% | 796,600 |
| 2022/06/07 | 4,330 | 4,379 | 4,320 | 4,354 | -11 | -0.3% | 801,400 |
| 2022/06/06 | 4,320 | 4,376 | 4,316 | 4,365 | +24 | +0.6% | 732,600 |
| 2022/06/03 | 4,342 | 4,368 | 4,321 | 4,341 | +24 | +0.6% | 771,000 |
| 2022/06/02 | 4,375 | 4,383 | 4,304 | 4,317 | -65 | -1.5% | 954,300 |
| 2022/06/01 | 4,340 | 4,432 | 4,324 | 4,382 | +93 | +2.2% | 1,198,600 |
| 2022/05/31 | 4,391 | 4,422 | 4,289 | 4,289 | -88 | -2% | 5,562,700 |
| 2022/05/30 | 4,349 | 4,410 | 4,330 | 4,377 | +46 | +1.1% | 1,250,000 |
| 2022/05/27 | 4,400 | 4,409 | 4,313 | 4,331 | -25 | -0.6% | 889,400 |
| 2022/05/26 | 4,409 | 4,441 | 4,354 | 4,356 | -71 | -1.6% | 1,167,200 |
| 2022/05/25 | 4,475 | 4,482 | 4,426 | 4,427 | -40 | -0.9% | 978,000 |
| 2022/05/24 | 4,498 | 4,509 | 4,462 | 4,467 | -36 | -0.8% | 819,300 |
| 2022/05/23 | 4,490 | 4,522 | 4,453 | 4,503 | +62 | +1.4% | 1,019,700 |
| 2022/05/20 | 4,474 | 4,494 | 4,435 | 4,441 | -44 | -1% | 1,392,100 |
| 2022/05/19 | 4,423 | 4,503 | 4,395 | 4,485 | -65 | -1.4% | 1,135,400 |
| 2022/05/18 | 4,486 | 4,555 | 4,478 | 4,550 | +103 | +2.3% | 1,412,700 |
| 2022/05/17 | 4,461 | 4,474 | 4,415 | 4,447 | +25 | +0.6% | 1,416,400 |
| 2022/05/16 | 4,350 | 4,504 | 4,350 | 4,422 | +106 | +2.5% | 1,095,400 |
| 2022/05/13 | 4,400 | 4,420 | 4,250 | 4,316 | -80 | -1.8% | 1,840,300 |
| 2022/05/12 | 4,396 | 4,417 | 4,339 | 4,396 | -25 | -0.6% | 855,800 |
| 2022/05/11 | 4,406 | 4,450 | 4,401 | 4,421 | -20 | -0.5% | 895,000 |
| 2022/05/10 | 4,424 | 4,451 | 4,405 | 4,441 | +2 | ±0% | 870,800 |
| 2022/05/09 | 4,495 | 4,506 | 4,419 | 4,439 | -84 | -1.9% | 936,900 |
| 2022/05/06 | 4,444 | 4,532 | 4,411 | 4,523 | +100 | +2.3% | 1,517,200 |
| 2022/05/02 | 4,351 | 4,430 | 4,303 | 4,423 | +60 | +1.4% | 1,225,600 |
| 2022/04/28 | 4,233 | 4,376 | 4,191 | 4,363 | +168 | +4% | 1,398,100 |
| 2022/04/27 | 4,239 | 4,239 | 4,165 | 4,195 | -85 | -2% | 1,497,700 |
| 2022/04/26 | 4,245 | 4,303 | 4,237 | 4,280 | +37 | +0.9% | 1,065,800 |
| 2022/04/25 | 4,217 | 4,254 | 4,195 | 4,243 | +10 | +0.2% | 742,900 |
| 2022/04/22 | 4,228 | 4,243 | 4,198 | 4,233 | -17 | -0.4% | 713,100 |
| 2022/04/21 | 4,215 | 4,282 | 4,173 | 4,250 | +75 | +1.8% | 895,500 |
| 2022/04/20 | 4,122 | 4,177 | 4,110 | 4,175 | +47 | +1.1% | 670,900 |
| 2022/04/19 | 4,134 | 4,151 | 4,108 | 4,128 | +12 | +0.3% | 553,700 |
| 2022/04/18 | 4,171 | 4,184 | 4,081 | 4,116 | -100 | -2.4% | 514,900 |
| 2022/04/15 | 4,203 | 4,236 | 4,174 | 4,216 | -24 | -0.6% | 475,400 |
| 2022/04/14 | 4,193 | 4,258 | 4,190 | 4,240 | +41 | +1% | 481,800 |
| 2022/04/13 | 4,126 | 4,213 | 4,125 | 4,199 | +22 | +0.5% | 856,900 |
| 2022/04/12 | 4,221 | 4,235 | 4,168 | 4,177 | -61 | -1.4% | 707,300 |
| 2022/04/11 | 4,230 | 4,247 | 4,202 | 4,238 | +1 | ±0% | 810,600 |
| 2022/04/08 | 4,282 | 4,282 | 4,228 | 4,237 | -4 | -0.1% | 1,332,000 |
| 2022/04/07 | 4,180 | 4,248 | 4,159 | 4,241 | +59 | +1.4% | 934,800 |
| 2022/04/06 | 4,207 | 4,225 | 4,160 | 4,182 | -63 | -1.5% | 1,150,100 |
| 2022/04/05 | 4,300 | 4,303 | 4,210 | 4,245 | -36 | -0.8% | 1,024,100 |
| 2022/04/04 | 4,260 | 4,302 | 4,232 | 4,281 | +59 | +1.4% | 649,000 |
| 2022/04/01 | 4,211 | 4,225 | 4,149 | 4,222 | -10 | -0.2% | 858,500 |
601～
650
件表示中 / 3412件
類似銘柄と比較する
現在ご覧いただいている「大塚ＨＤ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 大塚ＨＤ | 891,000円 | +14.4% | +120.8% | 1.35% | 20.00倍 | 1.83倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| 第一三共 | 443,500円 | +14.3% | +20.1% | 1.35% | 37.27倍 | 5.17倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
| 武 田 | 411,300円 | +5.1% | +76.2% | 4.77% | 95.87倍 | 0.94倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位１０強入り |
| アステラス薬 | 156,200円 | +12.2% | +180.3% | 4.74% | 55.93倍 | 1.83倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 209,400円 | +5.7% | +3.9% | 2.74% | 10.42倍 | 1.38倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
市場注目の銘柄
チャート関連のコラム
